Home > National Drug Code (NDC) > Loxapine Succinate

Loxapine Succinate - 49349-212-02 - (Loxapine Succinate)

Alphabetical Index


Drug Information of Loxapine Succinate

Product NDC: 49349-212
Proprietary Name: Loxapine Succinate
Non Proprietary Name: Loxapine Succinate
Active Ingredient(s): 50    mg/1 & nbsp;   Loxapine Succinate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Loxapine Succinate

Product NDC: 49349-212
Labeler Name: REMEDYREPACK INC.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA072062
Marketing Category: ANDA
Start Marketing Date: 20110426

Package Information of Loxapine Succinate

Package NDC: 49349-212-02
Package Description: 30 CAPSULE in 1 BLISTER PACK (49349-212-02)

NDC Information of Loxapine Succinate

NDC Code 49349-212-02
Proprietary Name Loxapine Succinate
Package Description 30 CAPSULE in 1 BLISTER PACK (49349-212-02)
Product NDC 49349-212
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Loxapine Succinate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20110426
Marketing Category Name ANDA
Labeler Name REMEDYREPACK INC.
Substance Name LOXAPINE SUCCINATE
Strength Number 50
Strength Unit mg/1
Pharmaceutical Classes

Complete Information of Loxapine Succinate


General Information